The Bio Pharmaceuticals Zone at CPHI Japan 2026 is a specialized exhibition area focusing on bio pharmaceuticals, including antibodies, middle molecules, and gene pharmaceuticals. With over half of the world's top 10 pharmaceutical sales being comprised of bio pharmaceuticals, the industry is expected to continue to grow in the future, with many pharmaceutical companies actively pursuing the development of bio pharmaceuticals. However, the development, research, and production of bio pharmaceuticals require specialized knowledge and expertise, which can be a challenge for pharmaceutical companies.

The zone will feature a variety of exhibitors, including global companies with a strong track record in the bio pharmaceutical field, as well as domestic companies, showcasing their products and services such as contract manufacturing, gene editing technology, protein extraction and purification, protein and peptide synthesis, cell culture and microbial cultivation, and more. The exhibition will also include a seminar and presentation program, featuring the latest technologies and trends in bio pharmaceuticals, including antibody pharmaceuticals, middle molecules, cell pharmaceuticals, and gene therapy. The seminar will cover topics such as the latest developments and future prospects in these fields.

The event will also include a business matching system, where exhibitors can pre-research and set up meetings with potential partners and suppliers from around the world. The exhibition is open to pharmaceutical companies, bio venture companies, public research institutions, and academia involved in the research, development, and production of bio pharmaceuticals. The event will provide a platform for exhibitors to showcase their products and services, and for attendees to learn about the latest technologies and trends in the field.